The National Health Service (NHS) in England recently released two studies that provide the first information available about risks of COVID-19 in peo...Read More
Toronto, ON, May 14, 2020 – Dr. Rangarajan Sambathkumar, a pioneering young investigator at the University Health Network in Toronto, has been awarded a second post-doctoral fellowship ($60,000) for his stem cell research, based on an ongoing collaboration between JDRF Canada and Eli Lill...
The JDRF - Beyond Type 1 Alliance Releases Recommendations for People with Diabetes During COVID-19 Pandemic
The recommendations are supported by 50 international organizations working together to curb the spread of COVID-19 and protect those most vulnerable.
JDRF Calgary cancels in-person "Picks and Plates" Gala Organization taking steps in response to Coronavirus Outbreak
Calgary, AB – March, 13 2020 – In response to concerns regarding the global Coronavirus outbreak, JDRF Calgary has cancelled its popular “Picks and Plates” Gala while continuing the event’s online fundraising activities. The in-person event was scheduled to ta...
Toronto, ON – March 3, 2020 – JDRF Canada, the leading global funder of type 1 diabetes (T1D) research, welcomes the release of the Standing Committee on Finance’s report and its recommendations to address the diabetes epidemic.
Toronto, Ontario – February 27, 2020 – JDRF Canada, the leading global funder of type 1 diabetes (T1D) research, is hopeful that the Government of Quebec might still consider provincial coverage for Continuous Glucose Monitoring (CGM) in spite of a report released this mon...
MONTREAL, October 25, 2019 – Montreal Canadiens centre and JDRF ambassador, Max Domi, unveiled The Max Domi Fund for Type 1 Diabetes today at the Bell Sports Complex.
TORONTO, October 2nd, 2019 – JDRF welcomes the Conservative announcement yesterday committing to legislation making it easier for Canadians with type 1 diabetes (T1D) and others to qualify for the Disability Tax Credit (DTC).
Interview opportunity: JDRF celebrates the announcement of Dexcom G6 CGM System's availability in Canada
JDRF shares the excitement of the type 1 diabetes community around today’s arrival of the Dexcom G6,” said Dave Prowten, President and CEO of JDRF Canada. “While JDRF remains focused on our goal to cure type 1 diabetes, we welcome the arrival of new and innovative technologies...
- Inaugural JDRF-led initiative provides grants of $5,000 each for a total of $105,000 to cover tuition and book costs -